Immunology: You Can't Make a Silk Purse Out of a Sow's Ear

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".

Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 397

Special Issue Editor


E-Mail Website
Guest Editor
Institute for Biomedical Aging Research, Medizinische Universitat Innsbruck, Innsbruck, Austria
Interests: immunology; ageing; infection; patient-reported outcome measures; cancer pediatrics

Special Issue Information

Dear Colleagues,

This thematic Special Issue will focus on the immune system as an active participant in health and diseases. Immunology is one of the most complex fields of life science and a highly competitive research field to publish new and rare ideas and findings, in particular for young scientists. Millions of scientists utilize their expertise in medicine and biology to focus on autoimmune diseases, cancer, immunodeficiency’s, age-associated impairments (immune-aging) and other immune disorders to help patients and cure diseases. Aim of this special issue is to provide an overview and an update on trends in clinical translation of basic research in immunology with special focus on aging.

In this Special Issue, entitled “Immunology: You can't make a silk purse out of a sow's ear”, we invite the submission of original research and comprehensive review on this field particularly which lie outside the current scientific understanding with high scientific and transformative potential.

Dr. Andreas Meryk
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • basic research immunology
  • clinical translation
  • aging (of the immune system)
  • immuno-aging
  • cancer
  • immune-biology
  • T-cells
  • B-cells

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop